@hmg88 kanger more potential than solution. Cansino phase III trial will only be completed 2022. Sinopharm vaccine phase III trial will be fully completed this month or next month.
Sao Paulo’s Instituto Butantan, which partnered with Sinovac to produce the vaccine locally, said in a statement it was surprised by the decision and is looking into details of what happened in the study. Director Dimas Covas said in a TV interview that one volunteer in the trial has died, but that the death is not related to the vaccine.
Sinovac’s company representative did not immediately respond to a request for comment.
Halts to investigate serious adverse events are not uncommon in large-scale drug trials and two western developers - AstraZeneca Plc and Johnson & Johnson -- have paused their vaccine trials in recent months due to such incidents, only to re-start them after investigation.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
HuatEveryday
475 posts
Posted by HuatEveryday > 2020-11-09 14:14 | Report Abuse
Hahaha because his info has been reliable so far but still own self to decide buy sell